Clinical Trial Update: Early Changes in OCT Biomarkers After the First Intravitreal Anti-VEGF Injection in Treatment-naïve DME

View source ↗

Summary

This clinical trial update describes a study evaluating early OCT biomarker changes after the first intravitreal anti-VEGF injection in treatment-naïve diabetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Intravitreal anti-VEGF (unspecified)

Snippet

Sponsor: Sohag University | Conditions: Early OCT Biomarker Changes in Response to Anti-VEGF | Status: ENROLLING_BY_INVITATION